Published in Cancer Res on July 01, 1995
Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A (1998) 2.40
Regulation of telomerase activity in immortal cell lines. Mol Cell Biol (1996) 1.82
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut (2005) 1.66
Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci U S A (1997) 1.51
Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A (1996) 1.42
Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci U S A (1995) 1.36
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J (1996) 1.23
Telomere, telomerase and digestive cancer. World J Gastroenterol (1999) 1.13
Telomerase in the early detection of cancer. J Clin Pathol (1997) 1.07
Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol (1998) 1.03
Telomerase activity in 144 brain tumours. Br J Cancer (1998) 0.97
Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg (1999) 0.96
Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br J Cancer (1997) 0.93
Telomerase activation in nasopharyngeal carcinomas. Br J Cancer (1998) 0.92
Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol (1997) 0.92
A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J Cancer Res Clin Oncol (1997) 0.91
Telomerase activity in gestational trophoblastic disease. J Clin Pathol (1999) 0.89
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer (1997) 0.86
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations. World J Gastroenterol (2015) 0.86
Increased telomerase activity and hTERT expression in human salivary gland carcinomas. Oncol Lett (2011) 0.84
Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence. J Gastroenterol (1997) 0.84
Telomerase activity in skeletal sarcomas. Ann Surg Oncol (1999) 0.82
p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro. World J Gastroenterol (2007) 0.80
Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads. Br J Cancer (2000) 0.79
Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response. BMC Cancer (2006) 0.79
Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma. World J Gastroenterol (2004) 0.79
Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection. World J Surg (2007) 0.78
DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis. Chemistry (2013) 0.78
Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br J Cancer (2000) 0.77
Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. World J Gastroenterol (2004) 0.77
Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin. World J Gastroenterol (2002) 0.77
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes. PLoS One (2017) 0.75
Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators. Biomed Res Int (2015) 0.75
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet (1997) 6.69
Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61
A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol (1992) 6.56
Telomerase activity in human germline and embryonic tissues and cells. Dev Genet (1996) 5.00
Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet (1999) 4.22
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature (2000) 3.96
Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol (1989) 3.89
Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation (1999) 3.74
Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med (1995) 3.74
Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev (1997) 3.42
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol (1995) 3.20
Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev (1999) 3.19
Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res (1995) 3.16
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev (2001) 3.16
Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer (1998) 3.12
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
Logic circuits with carbon nanotube transistors. Science (2001) 2.98
A novel NMR method for determining the interfaces of large protein-protein complexes. Nat Struct Biol (2000) 2.86
Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med (2000) 2.81
Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol (1999) 2.77
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res (1998) 2.72
The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem (2001) 2.69
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev (1997) 2.68
The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology (1984) 2.65
Telomere position effect in human cells. Science (2001) 2.61
Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A (1999) 2.36
Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res (1994) 2.28
Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet (1998) 2.27
Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst (1995) 2.18
Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (1999) 2.18
Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene (1994) 2.18
Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem (2000) 2.14
Simple, rapid, quantitative, and sensitive detection of telomere repeats in cell lysate by a hybridization protection assay. Clin Chem (1999) 2.11
Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun (1992) 2.11
Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res (1995) 2.11
Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem (1994) 2.09
Telomerase activity in gastric cancer. Cancer Res (1995) 2.02
The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol (1993) 1.98
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest (2001) 1.97
A low concentration of nitrous oxide reduces dyspnoea produced by a combination of hypercapnia and severe elastic load. Br J Anaesth (1999) 1.97
Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol Cell Biol (1999) 1.96
The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet (2000) 1.93
Telomere positional effects and the regulation of cellular senescence. Trends Genet (1992) 1.90
Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res (1994) 1.88
Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res (1996) 1.87
Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res (1996) 1.87
Ultrasonographic assessment of inflammatory bowel disease. Am J Gastroenterol (1992) 1.84
Regulation of telomerase activity in immortal cell lines. Mol Cell Biol (1996) 1.82
Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology (2005) 1.78
Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev (2001) 1.78
Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet (1992) 1.76
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol (1998) 1.75
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res (2001) 1.73
Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res (2000) 1.73
Telomerase activity in human breast tumors. J Natl Cancer Inst (1996) 1.73
Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang. J Biol Chem (2000) 1.73
Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg Am (1978) 1.70
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67
Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A. J Biol Chem (2000) 1.66
Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins. Proc Natl Acad Sci U S A (1986) 1.64
Telomerase activity in human brain tumours. Lancet (1995) 1.64
Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem (2000) 1.61
Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res (1994) 1.61
Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol (1993) 1.60
Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene (1993) 1.59
Normal human telomeres are not late replicating. Exp Cell Res (1999) 1.57
Metabolic interactions of glucose, lactate, and beta-hydroxybutyrate in rat brain slices. Am J Physiol (1969) 1.56
Phlebosclerosis of the colon with positive anti-centromere antibody. Intern Med (1999) 1.55
Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol (1999) 1.55
Urea extraction of Z bands, intercalated disks, and desmosomes. J Ultrastruct Res (1968) 1.54
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem Biophys Res Commun (2000) 1.54
G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells. Oncogene (2006) 1.53
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet (1997) 1.52
Levels of hepatocyte growth factor in maternal serum and amniotic fluid. Am J Obstet Gynecol (1995) 1.52
Development and validation of an ultrasonographic activity index of Crohn's disease. Eur J Gastroenterol Hepatol (1999) 1.51
Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol (2000) 1.51
A temperature-sensitive mutant of human p53. EMBO J (1994) 1.51
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer (2013) 1.50
Telomerase activity in normal human epithelial cells. Oncogene (1996) 1.50
Differential effects of vecuronium on diaphragm and geniohyoid muscle in anaesthetized dogs. Br J Anaesth (1992) 1.49
A quantitative analysis of hemodynamic effects of the right ventricle included in the circulation of the Fontan procedure. Circulation (1991) 1.49
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia (2001) 1.48
Telomerase immortalization of human myometrial cells. Biol Reprod (2002) 1.48
Role of telomerase in cellular proliferation and cancer. J Cell Physiol (1999) 1.47
Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol (1996) 1.46
Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol (2001) 1.46
New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay. Clin Chem (1998) 1.46
The effect of vitamin A on contraction of the ductus arteriosus in fetal rat. Pediatr Res (2001) 1.46
Rapid growth and difficulty of early detection of scirrhous carcinoma of the stomach. Am J Gastroenterol (1992) 1.46
Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene (2000) 1.46